title: Endovascular treatment of renal artery thrombosis caused by umbilical artery catheterization.
abstract: Renal arterial thrombosis, usually in association with aortic thrombosis, has been reported as a result of prolonged neonatal umbilical artery catheterization. A case of renal artery thrombosis attributable to umbilical artery catheterization, resulting in malignant renovascular hypertension, in a 15-day-old neonate, treated by catheter-directed thrombolysis through the involuting umbilical artery, was studied. Resolution of systemic hypertension and partial return of right renal function followed rapid thrombus dissolution.
authors.affiliation: Department of Surgery, Department of Radiology, and Department of Pediatrics, University of Rochester School of Medicine and Dentistry, NY, USA.
authors.forename: R
authors.initials: R
authors.lastname: Greenberg
authors.forename: D
authors.initials: D
authors.lastname: Waldman
authors.forename: C
authors.initials: C
authors.lastname: Brooks
authors.forename: K
authors.initials: K
authors.lastname: Ouriel
authors.forename: W
authors.initials: W
authors.lastname: Pegoli
authors.forename: R
authors.initials: R
authors.lastname: Ryan
authors.forename: R
authors.initials: R
authors.lastname: Green
mesh_terms: D002404:Catheterization / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010960:Plasminogen Activators / Q000627:therapeutic use*; D012078:Renal Artery Obstruction / Q000188:drug therapy* / Q000209:etiology; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D014469:Umbilical Arteries; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator